Embassy Pharmaceutical & Chemicals Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Embassy Pharmaceutical & Chemicals Pharmaceutical Import Records from India — 2 Products, $800.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Embassy Pharmaceutical & Chemicals — Pharmaceutical Importer Profile (2026) | 2 Products, $800.0K Trade | TransData Nexus

Embassy Pharmaceutical & Chemicals

Pharmaceutical Importer · Nigeria · Respiratory & OTC Focus · $800.0K Total Trade · DGFT Verified

Embassy Pharmaceutical & Chemicals is a pharmaceutical importer based in Nigeria with a total trade value of $800.0K across 2 products in 1 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Embassy Pharmaceutical & Chemicals sources from 1 verified Indian supplier, with Laborate Pharmaceuticals India Limited accounting for 100.0% of imports.

Embassy Pharmaceutical & Chemicals — Import Portfolio & Supplier Network

Embassy Pharmaceutical & Chemicals import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Embassy Pharmaceutical & Chemicals?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Laborate Pharmaceuticals India Limited	$1.9M	98	100.0%

Embassy Pharmaceutical & Chemicals sources from 1 verified Indian supplier across 94 distinct formulations. The sourcing is highly concentrated — Laborate Pharmaceuticals India Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
1-980 kold time tablet (paracetamol BP 500MG, caffeine BP 25MG , pseudoephedrinehydrochloride bp30mg, chlorphenamine	$100.0K	2
1-980 kold time tablet (paracetamol BP 500MG, caffeine (anhydrous) BP 25MG , pseudoephedrine hydrochloride BP 30MG	$100.0K	2
1-841 embassy vit b12 INJ. 2ML(cyanocobalamin USP 1000mcg/ML (as anhydrous), phenol USP (as preservative) 0.5%w/v)	$96.5K	2
1-550 amcilin 250 capsule (ampicillin trihydrate BP 250MG)batchnos:apuc-001 to apuc-006 mfg.01/25 exp. 12/27 (200x10x10)	$50.0K	1
1-980 kold time tablet (paracetamol BP 500MG,caffeine (anhydrous) BP 25MG,pseudoephedrinehydrochloride BP 30MG	$50.0K	1
291-690 labohydro injection 100MG(hydrocortisone sodium succinate BP eq. to hydrocortisone 100MG) (qty: 8000 packs 5x10)	$50.0K	1
691-1026 iron dextron injection 5ML (iron dextran (a complex of iron (iii) hydroxide with dextrans) eq. to elemental	$50.0K	1
1-980 kold time tablet (paracetamol BP 500MG, caffeine (anhydrous) BP 25MG, pseudoephedrine hydrochloride BP 30MG	$50.0K	1
1-980 kold time tablet(paracetamol BP 500MG, caffeine (anhydrous) BP 25MG,pseudoephedrine hydrochloride BP 30MG	$50.0K	1
1-980 kold time tablet (paracetamol BP 500MG,caffeine (anhydrous) BP 25MG,pseudoephedrine hydrochloride BP 30MG	$50.0K	1
253-1337 labocof tablets (dextromethorphan hbr BP 10MG, guaifenesin BP 100MG, bromhexine hcl BP 8MG,chlorphenamine	$48.5K	1
1-1002 niphamshin capsule(oxytetracycline hydrochloride BP 250MG)(qty:50075 box10x1x12) batchnos:nipuc-001 to	$46.6K	1
1-1150 ketoral 200 tablet (ketoconazoleusp 200MG)(qty: 23000 Box 10x1x10)batchnos:kzut-001 mfg. 03/25 exp. 02/28	$46.4K	1
379-1304 ketoral 200 tablet (ketoconazole USP 200MG) (qty: 18510 Box 10x1x10) batchnos:kzut-001 & kzut-002 mfg. 03/25	$37.0K	1
1151-1598 medmoral tablet(trypsin-chymotrypsin (6:1) eq. to 50,000 units) (qty:13440 Box 10x3x10) batchnos:tcut-001 &	$33.8K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ephedrine	Respiratory & OTC	$400.0K	8	1.8%	8
2	Pseudoephedrine	Respiratory & OTC	$400.0K	8	3.4%	4

Embassy Pharmaceutical & Chemicals imports 2 pharmaceutical products across 1 categories into Nigeria totaling $800.0K.

Embassy Pharmaceutical & Chemicals — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Embassy Pharmaceutical & Chemicals Limited, established in 1986, is a prominent pharmaceutical importer and distributor based in Lagos, Nigeria. The company's administrative headquarters are located at 41, Ademola Street, South West Ikoyi, Lagos. (embassypharma.com.ng) With over 350 pharmaceutical products registered with the National Agency for Food and Drug Administration and Control (NAFDAC), Embassy Pharma offers a diverse range of medications across various therapeutic classes, including antineoplastics, antibacterials, analgesics, and more. (embassypharma.com.ng)

The company's mission is to become the most valuable entity in Nigeria's pharmaceutical industry by providing a wide array of world-class, quality, and efficacious pharmaceutical products at affordable prices. (embassypharma.com.ng) Embassy Pharma's extensive product portfolio underscores its significant role in the Nigerian pharmaceutical distribution network, catering to the diverse healthcare needs of the population.

2Distribution Network

Embassy Pharmaceutical & Chemicals Limited operates its distribution network from its headquarters in Lagos, Nigeria. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive product range and partnerships suggest a well-established distribution system. Embassy Pharma's geographic coverage primarily focuses on the Nigerian market, ensuring the availability of pharmaceutical products across the country.

3Industry Role

Embassy Pharmaceutical & Chemicals Limited functions as a primary wholesaler and distributor within Nigeria's pharmaceutical supply chain. By importing a wide array of pharmaceutical products and ensuring their availability throughout the country, the company plays a crucial role in bridging the gap between international manufacturers and the Nigerian healthcare system. Its extensive product portfolio and partnerships with global pharmaceutical entities highlight its significant position in the market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Embassy Pharmaceutical & Chemicals

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Embassy Pharmaceutical & Chemicals Limited's sourcing strategy exhibits a high degree of concentration, with a substantial portion of its imports originating from a single supplier, Laborate Pharmaceuticals India Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or geopolitical issues affecting the supplier's operations. However, the consistent volume of shipments and the long-standing relationship between Embassy Pharma and Laborate Pharmaceuticals suggest a stable and reliable partnership. The company's focus on a limited number of products, primarily ephedrine and pseudoephedrine, indicates a strategic choice to specialize in specific therapeutic areas, potentially enhancing expertise and operational efficiency.

2Supply Chain Resilience

Embassy Pharmaceutical & Chemicals Limited's supply chain resilience is closely tied to its reliance on Laborate Pharmaceuticals India Limited for a significant portion of its imports. The absence of publicly available information regarding backup suppliers and the diversity of formulations imported suggests a potential vulnerability to disruptions in the supply chain. Additionally, the company's focus on a limited number of products may limit its ability to adapt to changes in market demand or regulatory environments. Ensuring compliance with international quality standards and maintaining robust logistics capabilities are essential for mitigating potential risks associated with this sourcing strategy.

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, distribution, and sale of pharmaceutical products. NAFDAC's mandate includes ensuring that all drugs and related products meet established safety, efficacy, and quality standards before they enter the Nigerian market. The regulatory framework governing pharmaceutical imports is designed to protect public health by enforcing stringent guidelines and procedures for product registration, importation, and distribution.

2Import Licensing & GMP

Importers of pharmaceutical products into Nigeria must obtain the necessary licenses and approvals from NAFDAC. This process involves registering the pharmaceutical company with NAFDAC, ensuring that the company's premises meet regulatory standards, and obtaining import permits for each product. Additionally, the imported products must be manufactured in facilities that adhere to recognized Good Manufacturing Practice (GMP) standards, such as those certified by the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Embassy Pharmaceutical & Chemicals Limited's imports from Laborate Pharmaceuticals India Limited suggest that the supplier's manufacturing facilities comply with these international GMP standards.

Embassy Pharmaceutical & Chemicals — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Embassy Pharmaceutical & Chemicals Limited's focus on importing ephedrine and pseudoephedrine indicates a strategic emphasis on respiratory and over-the-counter (OTC) products. These products are commonly used in the treatment of respiratory conditions and as decongestants, addressing prevalent health issues in Nigeria. The market demand for such products is driven by the high incidence of respiratory ailments and the need for accessible OTC medications. By concentrating on these therapeutic areas, Embassy Pharma aligns its product strategy with the healthcare needs of the Nigerian population.

2Sourcing Profile

Embassy Pharmaceutical & Chemicals Limited's sourcing strategy is centered on importing generic formulations from India, particularly ephedrine and pseudoephedrine. This approach allows the company to offer cost-effective alternatives to branded medications, making essential treatments more accessible to Nigerian consumers. India's well-established pharmaceutical manufacturing industry, known for its adherence to international quality standards, complements Embassy Pharma's procurement strategy, ensuring the availability of high-quality products in the Nigerian market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Embassy Pharmaceutical & Chemicals

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by offering alternative products or formulations that align with Embassy Pharmaceutical & Chemicals Limited's existing portfolio. By diversifying its supplier base, Embassy Pharma can mitigate risks associated with single-source dependency and enhance its product offerings. Potential gaps in Embassy Pharma's current sourcing include the need for additional formulations in the respiratory and OTC categories, as well as products that address other prevalent health conditions in Nigeria.

2Requirements & Qualifications

Indian exporters seeking to supply products to Embassy Pharmaceutical & Chemicals Limited and the Nigerian market must ensure that their manufacturing facilities comply with recognized Good Manufacturing Practice (GMP) standards, such as those certified by the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, the products must be registered with NAFDAC, and the exporter must provide a notarized Power of Attorney authorizing a duly registered pharmaceutical company in Nigeria to act on their behalf.

How to Approach

Frequently Asked Questions — Embassy Pharmaceutical & Chemicals

What products does Embassy Pharmaceutical & Chemicals import from India?

Embassy Pharmaceutical & Chemicals imports 2 pharmaceutical products across 1 categories. Top imports: Ephedrine ($400.0K), Pseudoephedrine ($400.0K).

Who supplies pharmaceuticals to Embassy Pharmaceutical & Chemicals from India?

Embassy Pharmaceutical & Chemicals sources from 1 verified Indian suppliers. The primary supplier is Laborate Pharmaceuticals India Limited (100.0% of imports, $1.9M).

What is Embassy Pharmaceutical & Chemicals's total pharmaceutical import value?

Embassy Pharmaceutical & Chemicals's total pharmaceutical import value from India is $800.0K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Embassy Pharmaceutical & Chemicals focus on?

Embassy Pharmaceutical & Chemicals imports across 1 categories. The largest: Respiratory & OTC (100.0%).

Get Full Embassy Pharmaceutical & Chemicals Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.